Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis
Overactive bladder (OAB) is a chronic disease that correlates with the age of the patient, and occurs in almost one in seven women and men. Pharmacotherapy is one of the main methods for correction of this nosology. Taking into account the absence of additional therapeutic option on the Vital and Es...
Main Authors: | A. S. Kolbin, I. A. Vilium, M. A. Proskurin, Yu. E. Balykina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-06-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/213 |
Similar Items
-
Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021-04-01) -
Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy
by: A. S. Kolbin, et al.
Published: (2018-06-01) -
Osobennosti mocheispuskaniya u ginekologicheskikh bol'nykh
by: Irina Yur'evna Il'ina, et al.
Published: (2013-10-01) -
Economic analysis of the effectiveness of complex rehabilitation in children with spastic forms of cerebral palsy with injections of botulinum neurotoxin type A and without it
by: V. A. Zmanovskaya, et al.
Published: (2018-07-01) -
Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus
by: A. S. Kolbin, et al.
Published: (2021-02-01)